Introduction
Exercise‐induced arterial hypoxemia (EIAH) has been observed in highly trained endurance athletes during near maximal exercise, which may be influenced by a histamine‐mediated inflammatory response at the pulmonary capillary‐alveolar membrane. In order to test this hypothesis, we examined whether the mast cell stabilizer nedocromil sodium (NS) and H
1
‐receptor antagonist diphenhydramine HCL (DH) would ameliorate EIAH and mitigate the drop in arterial oxyhemoglobin saturation (S
a
O
2
) during intensive exercise.
Methods
Seven highly trained male cross country runners (age, 21 ± 2 years; V̇O
2max
, 74.7 ± 3.5 ml·kg
−1
·min
−1
) participated in the study. All subjects completed a maximal exercise treadmill test to exhaustion, followed by three 5‐min constant‐load exercise bouts at 70%, 80%, and 90% V̇O
2max
. Prior to testing, subjects received either placebo (PL), NS, or DH.
Results
Compared to PL, there was a significant treatment effect on S
a
O
2
(
p
< 0.001) for both NS and DH during both constant‐load exercise and at V̇O
2max
. Post hoc tests revealed S
a
O
2
values, compared to PL, were significantly higher at V̇O
2max
and during DH trials and higher with NS at constant‐load intensities except at 70% (
p
= 0.13).
Conclusion
The findings provide further evidence that histamine contributes directly or indirectly to the development of EIAH during intense exercise in highly trained athletes.